论文部分内容阅读
本文采用单克隆，多克隆双抗体夹心ＥＬＩＳＡ检测了３５例喉鳞癌患者，３０例喉良性肿瘤对照组患者和２５例正常人的血清ＳＩＬ－２Ｒ水平，结果显示喉癌组血清ＳＩＬ－２Ｒ水平显著高于良性组（Ｐ＜０．００１）和正常人（Ｐ＜０．００１），而良性组和正常人之间血清ＳＩＬ－２Ｒ水平无显著差异（Ｐ＞０．０５）。提示血清ＳＩＬ－２Ｒ水平检测可做为喉癌诊断的一项辅助指标。
Serum SIL-2R levels in 35 patients with laryngeal squamous cell carcinoma, 30 patients with laryngeal benign tumor and 25 normal controls were detected by monoclonal and polyclonal antibody sandwich ELISA. The results showed that serum SIL-2R level (P <0.001) and normal subjects (P <0.001). There was no significant difference in serum SIL-2R between benign and normal controls (P> 0.05). It is suggested that the serum SIL-2R level can be used as a supplementary indicator for the diagnosis of laryngeal cancer.